Perigon Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-19,623
Closed -$1.98M 288
2019
Q3
$1.98M Sell
19,623
-3,511
-15% -$334K 0.47% 48
2019
Q2
$2.14M Sell
23,134
-8,820
-28% -$838K 0.5% 45
2019
Q1
$3M Buy
31,954
+400
+1% +$35K 0.7% 39
2018
Q4
$2.77M Sell
31,554
-759
-2% -$56K 0.71% 36
2018
Q3
$2.89M Hold
32,313
0.71% 38
2018
Q2
$2.57M Sell
32,313
-3,770
-10% -$313K 0.77% 39
2018
Q1
$3.22M Sell
36,083
-1,800
-5% -$173K 1.19% 24
2017
Q4
$3.95M Buy
37,883
+55
+0.1% +$6.21K 1.48% 19
2017
Q3
$5.52M Sell
37,828
-9,482
-20% -$1.29M 1.79% 10
2017
Q2
$6.14M Buy
47,310
+330
+0.7% +$40.4K 1.34% 12
2017
Q1
$5.85M Buy
46,980
+726
+2% +$86.9K 1.24% 13
2016
Q4
$5.72M Buy
46,254
+6,578
+17% +$733K 1.25% 16
2016
Q3
$4.15M Sell
39,676
-4
-0% -$433 1.07% 26
2016
Q2
$3.91M Hold
39,680
1.04% 24
2016
Q1
$3.97M Hold
39,680
1.24% 21
2015
Q4
$4.75M Sell
39,680
-460
-1% -$53.2K 1.31% 14
2015
Q3
$4.34M Sell
40,140
-1,140
-3% -$141K 1.29% 13
2015
Q2
$4.78M Sell
41,280
-14,345
-26% -$1.64M 1.26% 13
2015
Q1
$6.41M Buy
55,625
+110
+0.2% +$13.1K 1.76% 7
2014
Q4
$6.21M Sell
55,515
-120
-0.2% -$12.7K 1.87% 7
2014
Q3
$5.27M Buy
55,635
+960
+2% +$86.6K 1.57% 10
2014
Q2
$4.7M Sell
54,675
-725
-1% -$55.1K 1.34% 14
2014
Q1
$3.87M Buy
55,400
+196
+0.4% +$15.5K 2.13% 10
2013
Q4
$4.66M Buy
+55,204
New +$4.37M 2.59% 6

Other funds holding CELG

Perigon Wealth Management's CELG Position: Q4 2019 in Review

Perigon Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 19,623 shares — an estimated $1.98M sold.

Perigon Wealth Management first reported a position in CELG in Q4 2013 and held it in 24 quarters. The position peaked at $6.41M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Perigon Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Perigon Wealth Management sold 19,623 Celgene Corp shares in Q4 2019, an estimated $1.98M.
  • Perigon Wealth Management first reported a position in Celgene Corp in Q4 2013 and held it in 24 quarters.
  • Perigon Wealth Management's Celgene Corp position peaked at $6.41M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Perigon Wealth Management's 13F filing for Q4 2019, filed 13 Jan 2020.